Garden Grade I Subcapital Fracture of Femoral Neck Clinical Trial
— N-ForceOfficial title:
N-Force Screws Augmented With N-Force Blue in Intracapsular Proximal Femur Fracture Treatment
Verified date | May 2022 |
Source | Zimmer Biomet |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of this prospective study is to confirm safety and performance of N-Force Screws augmented with N-Force Blue applied in intracapsular proximal femur fracture treatment.
Status | Terminated |
Enrollment | 12 |
Est. completion date | March 11, 2021 |
Est. primary completion date | March 11, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years and older |
Eligibility | Inclusion Criteria: - Patient has primary Garden I or II intracapsular proximal femur fracture requiring surgical intervention and is eligible for fixation by three cannulated screws augmented with N-Force Blue. - Patient receives operative treatment within 7 days of injury. - Patient was ambulatory before injury. - Patient is 50 years of age or older. Exclusion Criteria: - Patient has Garden III or IV intracapsular proximal femur fracture. - Patient has major cognitive impairment (including dementia). - Patient is on dialysis. - Patient is not expected to survive follow-up schedule. - Patient is expected to have problems maintaining follow-up compliance, i.e. patients with no fixed address, patients not mentally competent to give informed consent, etc. (Investigator's discretion). - Patient is a prisoner. - Patient is known to be pregnant and/or breastfeeding. - Patient is a known alcohol or drug abuser. - Patient had previous/has active acute or chronic infections, especially at the site of operation. - Patient has non-viable bone, or has areas where surrounding bone is not viable or capable of supporting and anchoring the implant. - Patient has traumatic injuries with open wounds or close to the proximal femur fracture, which are likely to become infected. - Patient is expected to be non-compliant with recommended post-operative weight-bearing instructions. - Physical conditions, in the opinion of the investigator, that would prohibit adequate implant support or impede healing. |
Country | Name | City | State |
---|---|---|---|
United States | Donald B Slocum Research and Education Foundation | Eugene | Oregon |
United States | Washington University | Saint Louis | Missouri |
United States | University of Utah | Salt Lake City | Utah |
United States | Stanford University | Stanford | California |
Lead Sponsor | Collaborator |
---|---|
Zimmer Biomet |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Participants With a Reoperation | Reoperation after initial surgery to promote fracture healing, relieve pain, treat infection, or improve function. | 12 months | |
Secondary | Number of Participants With Radiographic Fracture Healing of the Intracapsular Femur (RUSH) | Radiographic fracture healing as seen on x-ray and defined using Radiographic Union Score for Hips (RUSH) scoring system. The RUSH quantifies four measures of healing: cortical bridging, cortical fracture disappearance, trabecular consolidation, and trabecular fracture disappearance. Cortical healing is assessed in four anatomic femoral neck regions (anterior, posterior, medial, lateral) and trabecular healing is measured with two assessments (fracture line disappearance and consolidation of matrix). Each of the 10 assessed dimensions of radiographic femoral neck healing are scored 1 to 3, leading to a minimum score of 10 (no signs of healing) and a maximum score of 30 (perfect healing). | 6 weeks, 3 months, 6 months, and 12 months | |
Secondary | Participant Steinberg Classification at 12 Months | Steinberg Classification is based on the radiographic appearance and location of lesion. It is concise and delineates the progression and extent of Avascular Necrosis (AVN) involvement more accurately.
[stage 0:] normal or non-diagnostic radiographs, MRI and bone scan of at risk hip (often contralateral hip involved, or patient has risk factors and hip pain) [stage I:] normal radiograph, abnormal bone scan and/or MRI [stage II:] cystic and sclerotic radiographic changes [stage III:] subchondral lucency or crescent sign [stage IV:] flattening of femoral head, with depression graded into mild: <2 mm moderate: 2-4 mm severe: >4 mm [stage V:] joint space narrowing with or without acetabular involvement [stage VI]: advanced degenerative changes |
12 months | |
Secondary | Average FIX-IT Score (Clinical Fracture Healing of the Intracapsular Femur) | The Function IndeX for Trauma (FIX-IT) score is an assessment tool for patients with lower extremity fractures, incorporating pain and the ability to weight-bear. The score utilizes two questions to assess the ability to bear weight and two questions to assess pain at the fracture site. The maximum subtotal for each set of questions is 6 points, yielding a maximum overall score of 12 points and a minimum score (lowest weight bearing and highest pain) of 0 points. | 6 weeks, 3 months, 6 months, and 12 months | |
Secondary | Average EQ-5D-5L Score (Clinical Fracture Healing of the Intracapsular Femur) | The EuroQol five dimensions questionnaire (EQ-5D-5L) is a five dimensional self-assessment that is comprised of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. These five dimensions can be used to index a subject's health utility on a scale of 0 to 1, where 0 is death and 1 is perfect health. The scoring rule for EQ-5D permits scores less than 0, implying that some health states may be worse than death.
The Health Status is scored on a VAS scale of 0 to 100, where 100 ('the best imaginable health state' or 'the best health state you can imagine') to 0 ('the worst imaginable health state' or 'the worst health you can imagine'). |
6 weeks, 3 months, 6 months, and 12 months | |
Secondary | Average Harris Hips Score (Clinical Fracture Healing of the Intracapsular Femur) | This will be measured using Harris Hip Score. This is quantified on a scale of 0-100 and the domains covered are pain, function, absence of deformity, and range of motion. The score is quantified on a scale of 0-100, with 100 points being the best possible outcome. The domains cover pain (1 item, 0-44 points), function (7 items, 0-47 points), absence of deformity (1 item, 4 points), and range of motion (2 items, 5 points). | 6 weeks, 3 months, 6 months, and 12 months | |
Secondary | Number of Participants That Performed Timed Up-and-Go Test (Clinical Fracture Healing of the Intracapsular Femur) | This will be measured using the Timed 'Up-and-Go' Test. It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.This test is used to assess a person's mobility and requires both static and dynamic balance. Scores of ten seconds or less indicate normal mobility, 11-20 seconds are within normal limits for frail elderly and disabled patients, and greater than 20 seconds means the person needs assistance outside and indicates further examination and intervention. A score of 30 seconds or more suggests that the person may be prone to falls. | 6 weeks, 3 months, 6 months, and 12 months | |
Secondary | Average Participant Time to Complete Timed Up-and-Go Test (Clinical Fracture Healing of the Intracapsular Femur) | This will be measured using the Timed 'Up-and-Go' Test. It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.This test is used to assess a person's mobility and requires both static and dynamic balance. Scores of ten seconds or less indicate normal mobility, 11-20 seconds are within normal limits for frail elderly and disabled patients, and greater than 20 seconds means the person needs assistance outside and indicates further examination and intervention. A score of 30 seconds or more suggests that the person may be prone to falls. | 6 weeks, 3 months, 6 months, and 12 months | |
Secondary | Cost-Effective Analysis | Analysis will be performed comparing N-Force to standard non-augmented cannulated screws. | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03870477 -
THP Hip Fracture Plating System Study
|
N/A |